Funded Tech Companies
Purespring Therapeutics
Purespring Therapeutics, operating out of London, received equity investments from Gilde Healthcare Partners, Syncona and Forbion Capital Partners.
Company Overview
Company Name
Purespring Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Rolling Stock Yard, 188 York Way
London, N7 9AS
UK
London, N7 9AS
UK
Phone
Website
Email Address
Company Background Information
Overview
Purespring is developing gene therapies to halt or prevent kidney disease, one of humankind's most poorly treated disease areas. Purespring's platform approach enables streamlined gene therapy development for both monogenic and non-monogenic renal diseases, offering the potential to halt, reverse and even cure both rare and common kidney diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/9/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
John Tsai
Chief Executive Officer
Julian Hanak
Chief Financial Officer
Sachin Kelkar
Chief Medical Officer
Fredrik Erlandsson
Chief Scientific Officer
Alice Brown
Co-Founder
Moin Saleem
VP - Human Resources
Peter Mulcahy
Company Investors
- Gilde Healthcare Partners
- Syncona
- Forbion Capital Partners
- Sofinnova Partners
- British Patient Capital
Browse more funded tech companies:
PureSpectrum | PureStream Trading Technologies
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs